Athina Mavrou
Affiliations: | 2010-2013 | University of Bristol, Bristol, England, United Kingdom |
Google:
"Athina Mavrou"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mavrou A, Oltean S. (2016) SRPK1 inhibition in prostate cancer: a novel anti-angiogenic treatment through modulation of VEGF alternative splicing. Pharmacological Research |
Mavrou A, Brakspear K, Hamdollah-Zadeh M, et al. (2014) Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer. Oncogene |
Mavrou A, Bates D, Oltean S. (2014) Abstract 2749: SRPK1 inhibition and modulation of VEGF alternative splicing as a potential therapeutic strategy in prostate cancer Cancer Research. 74: 2749-2749 |
Bates DO, Mavrou A, Qiu Y, et al. (2013) Detection of VEGF-A(xxx)b isoforms in human tissues. Plos One. 8: e68399 |
Mavrou A, Oltean S, Bates D. (2013) Abstract 380: Serine-Arginine protein kinase 1 (SRPK1) - A potential target of angiogenesis in prostate cancer. Cancer Research. 73: 380-380 |
Oltean S, Gammons M, Hulse R, et al. (2012) SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases. Biochemical Society Transactions. 40: 831-5 |
Oltean S, Neal CR, Mavrou A, et al. (2012) VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult mice. American Journal of Physiology. Renal Physiology. 303: F1026-36 |